What is PocDoc?
PocDoc operates at the intersection of mobile technology and clinical diagnostics. The company has developed a sophisticated platform that enables users to perform quantitative blood tests via a simple fingerprick, with results processed and contextualized through a smartphone or tablet interface. By focusing on preventative disease areas such as cardiovascular health and diabetes, PocDoc is effectively shifting the paradigm of routine health monitoring. Beyond its proprietary tests, the platform is engineered for interoperability, allowing for the digitization of various rapid tests and the creation of seamless follow-on care pathways. Having demonstrated its operational resilience during the pandemic through large-scale lateral flow testing partnerships with NHS Digital and the Department of Health, the company is now scaling its infrastructure to address global health challenges, including international polio eradication efforts in collaboration with PATH.
How much funding has PocDoc raised?
PocDoc has raised a total of $6.2M across 1 funding round:
Other Financing Round
$6.2M
Other Financing Round (2024): $6.2M with participation from MMC Ventures, Molten, and Simplyhealth Group
Key Investors in PocDoc
MMC Ventures
A venture capital firm specializing in scaling technology companies that transform markets, with a focus on deep technical understanding and long-term partnership.
Molten
A prominent venture capital firm dedicated to investing in high-growth technology companies with global ambitions and significant scalability potential.
Simplyhealth Group
A long-standing healthcare provider focused on everyday health needs, leveraging its extensive experience to support innovative digital health solutions.
What's next for PocDoc?
With this major enterprise-level funding, PocDoc is positioned to transition from a rapid-response diagnostic provider to a cornerstone of preventative healthcare infrastructure. The strategic roadmap likely involves expanding the breadth of its proprietary blood test portfolio and deepening its integration with existing clinical care pathways. By leveraging its proven ability to digitize complex diagnostic data, the company is set to enhance its market penetration within corporate health programs and public health initiatives. As the firm scales, the focus will remain on refining its algorithmic health assessments and expanding its footprint in regions where decentralized pathology is essential for effective disease management and long-term health outcomes.
See full PocDoc company page
